IMMY

Fungal Education Fridays: spotlight on Rapid, Reliable, and Early Detection of Candida Infections ??A March 2025 study published in Microorganisms by Laura Trovato, Maddalena Calvo, Concetta Ilenia Palermo, Maria Rita Valenti, and Guido Scalia highlights the power of PCR testing for diagnosing invasive candidiasis in ICU patients. Key findings include: ? 83.3% sensitivity & 94.3% specificity for PCR detection ? 87.5% positive predictive value & 91.7% negative predictive value ? Faster results than traditional culture methods ? Improved accuracy when combined with BDG testing Despite its non-inclusion in official diagnostic algorithms, the study concludes that Candida PCR assays are valuable diagnostic tools when used alongside serological markers and culture-based assays. The high sensitivity of molecular methods, combined with their strong negative predictive value, makes them essential for ruling out invasive candidiasis in high-risk patients. IMMY is proud to offer the CandID PCR assay, which provides results in 45 minutes and detects the six main causative species associated with IC. Inquire for availability in your region! ?? Read the full study: https://hubs.ly/Q03cNtrk0 ?? Learn more about CandID PCR: https://hubs.ly/Q03cNDYf0 #FungalDiagnostics #Candida #PCRTesting #InvasiveCandidiasis #ThinkFungus #FungalEducationFridays

??Wildfires & Valley Fever: A Growing Concern The impact of wildfires extends beyond the immediate devastation—disrupted soil can increase the risk of coccidioidomycosis (Valley Fever) in endemic areas. To help raise awareness, we’re sharing this insightful webinar hosted by Mycoses Study Group Education & Research Consortium (MSGERC). ?? Coccidioidomycosis: Clinical Considerations in the Aftermath of Wildfires (Recorded March 12). This session intends to equip clinicians with vital knowledge on diagnosis, treatment, and reporting. ??Part I – Dr. GR Thompson explores wildfire-driven outbreaks and Valley Fever epidemiology. ?? Part II – Dr. Fariba Donovan discusses clinical presentations, diagnosis, and treatment strategies. ?? Watch now: https://hubs.ly/Q03cNWMq0 #ValleyFever #Coccidioidomycosis #MSGERC

Our Fungal Update poster on Histoplasma antigen testing using IMMY Clarus Histoplasma EIA kit - thanks to Nicholas Parham and the team at Alpha Labs who sponsored the poster and the distributors for IMMY Clarus products in the UK

?? IMMY is proud to offer a full spectrum of fungal diagnostic solutions tailored to every provider. From our trusted lateral flow assays, high-volume EIAs, and Immunodiffusion reagents to our cutting-edge real-time PCR diagnostics for Candida, C. auris, Aspergillus, and Pneumocystis jirovecii, we are committed to advancing laboratory medicine with accuracy and accessibility. Now, laboratorians can make species-specific identifications with IMMY’s highly sensitive and specific PCR assays—bringing clarity to areas long underserved. ?? Ready to enhance your diagnostic capabilities? Inquire about availability in your region today by filling out the form linked below! https://lnkd.in/gFbDeKSf #FungalDiagnostics #PCR #LabMedicine #ThinkFungus #Candida #Cauris #Aspergillus #Pneumocystis

???? Faster Valley Fever Detection for Veterinary Clinics! IMMY’s Coccidioides Antibody Lateral Flow Assay delivers highly sensitive and specific results in just 45 minutes—helping vets diagnose Valley Fever faster and start treatment sooner. Plus, switching to our in-house rapid test can reduce costs by up to 68% compared to send-out testing. Make the switch today: https://hubs.ly/Q03bRXW70 #VeterinaryDiagnostics #ValleyFever #RapidTesting #FungalDiagnostics

?? IMMY is headed to London for Fungal Update: Mycology 2025! Join us this weekend, March 14-15, at the Queen Elizabeth II Centre, where Greg Kowald, Director of Business Development for Europe, will be showcasing IMMY’s full range of rapid, accurate fungal diagnostics at booth 3. ?? Don’t miss two key presentations by Gemma Johnson, IMMY's Director of Product Development, on Saturday: ?? 12:35 – The Continuous Journey of Bringing Diagnostics Closer to the Patient ?? 14:45 – The Gains and the Gaps in Fungal POC Diagnostics Stop by our booth or attend these insightful sessions to learn how IMMY is advancing fungal diagnostics worldwide! ?? #FungalUpdate2025 #MedicalMycology #FungalDiagnostics #ThinkFungus #TestFungus

Lateral flow tests (LFTs), widely recognized from the COVID-19 pandemic, are emerging as powerful diagnostic tools beyond infectious diseases. They’re being developed for stroke detection, sepsis diagnosis, and even environmental testing, thanks to growing awareness and expanded manufacturing IMMY has long recognized the power of LFTs in infectious disease diagnostics, particularly in the field of medical mycology. IMMY’s lateral flow assays provide rapid, accessible testing for life-threatening fungal infections, including cryptococcosis, aspergillosis, and coccidioidomycosis. These tests reduce the need for specialized equipment, allowing clinicians to make timely, informed treatment decisions. IMMY’s accurate, affordable innovations are revolutionizing fungal diagnostics. With ongoing advancements in sensitivity, specificity, and sustainability, LFTs continue to push the boundaries of diagnostic medicine. IMMY remains at the forefront of this movement, continuously improving fungal diagnostics to meet the growing global need for rapid, reliable testing. ??Read the full article: https://hubs.ly/Q03b96sc0 ??Learn more about IMMY’s fungal diagnostics here: https://hubs.ly/Q03b96y30

?? Redefining AFB Processing with MycoDDR MycoDDR ensures a controlled, reliable digestion and decontamination process, leading to faster culture results, improved smear quality, and reduced lab variability. But don’t just take our word for it—hear from Joselito C. Laguesma, Supervisor of Transfusion Services & Microbiology at Medical Center Health System in Odessa: "Overall our experience with the MycoDDR Reagents has been very positive. Strengths include: ease of use, reduced contamination, fewer false positives... Since implementing MycoDDR, we've seen less contamination and an increase in positive MGIT results, which is not due to contamination." It’s time to redefine AFB processing. It all starts with MycoDDR. #MycoDDR #AFBProcessing #IMMYInnovation

?? New Publication: Advancing Histoplasmosis Screening in People Living with HIV IMMY’s Diego Hernando Caceres Contreras recently collaborated with researchers in Southern Brazil to evaluate systematic Histoplasma antigen screening in people living with HIV using the IMMY HGM-EIA. Their findings, published in Medical Mycology, underscore the critical role of early histoplasmosis detection in reducing mortality in this vulnerable population. ?? Over an 18-month period, 287 individuals were screened, revealing a 9.1% positivity rate, with significantly higher detection in hospitalized patients. The study highlights the impact of proactive screening, leading to earlier diagnosis and timely treatment, which can ultimately save lives. ??Read the full study: "Histoplasmosis screening using urinary antigen detection in people living with HIV in Southern Brazil" https://hubs.ly/Q0392whz0 Authors: Bianca Dos Santos Blan, Vanice Rodrigues Poester, Rossana Patricia Basso, Karine Ortiz Sanchotene, Diego H Caceres, Ivy Bastos Ramis de Souza, Alessandro C Pasqualotto, Melissa Orzechowski Xavier. #Histoplasmosis #HIV #FungalDiagnostics #MedicalMycology #IMMYDiagnostics

?? Advancing Fungal Diagnostics in Vietnam IMMY’s Senior VP of Business and Product Development, JT Harrison, recently traveled to Vietnam to further our mission of ensuring widespread access to accurate, rapid, and affordable fungal diagnostics. His engagements included: ?? Feb. 18 – Inaugural Vietnam National Fungal Diseases Workshop | National Hospital for Tropical Diseases A gathering of thought leaders, clinicians, and policymakers to address the burden of fungal diseases in Vietnam and explore sustainable solutions for improved diagnosis, treatment, and collaboration. ?? Feb. 19-20 – AIDS-related Mycoses Network Meeting | Hanoi Medical University A critical meeting focused on ending cryptococcal meningitis deaths by 2030 and advancing the fight against AIDS-related mycoses. The discussion brought together experts from various sectors to enhance clinical approaches, research, and policy initiatives for advanced HIV disease (AHD). At IMMY, we remain committed to supporting global initiatives that drive innovation and accessibility in fungal disease diagnostics. ???? #FungalDiagnostics #GlobalHealth #InfectiousDiseases #AdvancedHIV #CryptococcalMeningitis #IMMY #ThinkFungus